Yevgeny Ruzhitsky

Provides investment banking, securities trading and brokerage Services

Cowen Investment Management invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceutical and healthcare services. It provides financing for early and late stage capital requirements. Cowen Investment Management reorganized its healthcare operating segments on December 1, 2023, by combining Cowen Healthcare Investments into a single segment called Blue Owl Healthcare Opportunities Advisors LLC.

NBBD-IM offers clients investment solutions across asset classes, styles, capitalizations and geographies in both public and private markets, as well as multi-asset class solutions that bring them all together. For equity investments, the firm tends to focus on stocks with solid balance sheets, relatively low price-to-earnings ratios, low price-to-cash flow ratios, strong cash flows, above-average yields, sustainable earnings growth, reasonable valuation multiples relative to growth prospects, sound franchise values and significant insider ownership. They use both top-down and bottom-up analysis to select investments. In addition, the firm uses options and futures and occasionally invests in ADRs and private equity opportunities.

EPIM seeks to achieve long-term appreciation of capital investing in a broad range of domestic, foreign and emerging market securities. The firm’s research and analysis not only focus on company specific data, but also considers broader market and economic factors. Their investment decisions are based on a thorough study of candidate companies’ public materials, often supplemented by interviews with management, suppliers, competitors and customers and visits to candidate companies’ facilities.

Functions as a College/University